@article{b99be0d03f0143fc87d1e60d8375dd0b,
title = "Bi-allelic Recessive Loss-of-Function Variants in FANCM Cause Non-obstructive Azoospermia",
abstract = "Infertility affects around 7% of men worldwide. Idiopathic non-obstructive azoospermia (NOA) is defined as the absence of spermatozoa in the ejaculate due to failed spermatogenesis. There is a high probability that NOA is caused by rare genetic defects. In this study, whole-exome sequencing (WES) was applied to two Estonian brothers diagnosed with NOA and Sertoli cell-only syndrome (SCOS). Compound heterozygous loss-of-function (LoF) variants in FANCM (Fanconi anemia complementation group M) were detected as the most likely cause for their condition. A rare maternally inherited frameshift variant p.Gln498Thrfs∗7 (rs761250416) and a previously undescribed splicing variant (c.4387−10A>G) derived from the father introduce a premature STOP codon leading to a truncated protein. FANCM exhibits enhanced testicular expression. In control subjects, immunohistochemical staining localized FANCM to the Sertoli and spermatogenic cells of seminiferous tubules with increasing intensity through germ cell development. This is consistent with its role in maintaining genomic stability in meiosis and mitosis. In the individual with SCOS carrying bi-allelic FANCM LoF variants, none or only faint expression was detected in the Sertoli cells. As further evidence, we detected two additional NOA-affected case subjects with independent FANCM homozygous nonsense variants, one from Estonia (p.Gln1701∗; rs147021911) and another from Portugal (p.Arg1931∗; rs144567652). The study convincingly demonstrates that bi-allelic recessive LoF variants in FANCM cause azoospermia. FANCM pathogenic variants have also been linked with doubled risk of familial breast and ovarian cancer, providing an example mechanism for the association between infertility and cancer risk, supported by published data on Fancm mutant mouse models.",
keywords = "FANCM, SCOS, Sertoli cell-only syndrome, bi-allelic loss-of-function variants, genetic cause of male infertility, immunohistochemistry, non-obstructive azoospermia, prostate, spermatogenesis, testicular biopsy, whole-exome sequencing",
author = "{GEMINI Consortium} and Laura Kasak and Margus Punab and Liina Nagirnaja and Marina Grigorova and Ave Minajeva and Lopes, {Alexandra M.} and Punab, {Anna Maria} and Aston, {Kenneth I.} and Filipa Carvalho and Eve Laasik and Smith, {Lee B.} and Conrad, {Donald F.} and Maris Laan",
note = "Funding Information: The study was supported by the European Union through the European Regional Development Fund (project HAPPY PREGNANCY, 3.2.0701.12-0047; for M.L. and M.P.), the Estonian Research Council (grants IUT34-12 for M.L. and PUT181 to M.P.), and the National Institutes of Health of the United States of America (R01HD078641 to D.F.C. and K.I.A. and R01MH101810 to D.F.C.). Some work on this project was conducted while D.F.C. was visiting the University of Tartu under the support of a grant from the United States Department of State (Fulbright Project #P000086). A.M.L. is funded by the Portuguese Government through FCT (IF/01262/2014). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274). L.B.S. is funded by a MRC (UK) Programme Grant number MR/N002970/1. Funding Information: The study was supported by the European Union through the European Regional Development Fund (project HAPPY PREGNANCY, 3.2.0701.12-0047; for M.L. and M.P.), the Estonian Research Council (grants IUT34-12 for M.L. and PUT181 to M.P.), and the National Institutes of Health of the United States of America (R01HD078641 to D.F.C. and K.I.A. and R01MH101810 to D.F.C.). Some work on this project was conducted while D.F.C. was visiting the University of Tartu under the support of a grant from the United States Department of State (Fulbright Project #P000086). A.M.L. is funded by the Portuguese Government through FCT (IF/01262/2014). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT in the framework of the project ?Institute for Research and Innovation in Health Sciences? (POCI-01-0145-FEDER-007274). L.B.S. is funded by a MRC (UK) Programme Grant number MR/N002970/1. Funding Information: The study was supported by the European Union through the European Regional Development Fund (project HAPPY PREGNANCY, 3.2.0701.12-0047 ; for M.L. and M.P.), the Estonian Research Council (grants IUT34-12 for M.L. and PUT181 to M.P.), and the National Institutes of Health of the United States of America ( R01HD078641 to D.F.C. and K.I.A. and R01MH101810 to D.F.C.). Some work on this project was conducted while D.F.C. was visiting the University of Tartu under the support of a grant from the United States Department of State (Fulbright Project # P000086 ). A.M.L. is funded by the Portuguese Government through FCT ( IF/01262/2014 ). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT in the framework of the project “Institute for Research and Innovation in Health Sciences” ( POCI-01-0145-FEDER-007274 ). L.B.S. is funded by a MRC (UK) Programme Grant number MR/N002970/1 . Publisher Copyright: {\textcopyright} 2018 American Society of Human Genetics",
year = "2018",
month = aug,
day = "2",
doi = "10.1016/j.ajhg.2018.07.005",
language = "English (US)",
volume = "103",
pages = "200--212",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "2",
}